中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

半胱氨酰白三烯受体1在胰腺癌组织中的表达及临床意义

孟艳 朱莹 张亚庆 邹凌云 张秋楠

鹿宁宁, 孙斌, 崔雄伟, 龙江, 高文峰, 郑加生. 肝肿瘤消融术后肝包膜下出血的诊断与治疗[J]. 临床肝胆病杂志, 2017, 33(12): 2326-2330. DOI: 10.3969/j.issn.1001-5256.2017.12.014.
引用本文: 鹿宁宁, 孙斌, 崔雄伟, 龙江, 高文峰, 郑加生. 肝肿瘤消融术后肝包膜下出血的诊断与治疗[J]. 临床肝胆病杂志, 2017, 33(12): 2326-2330. DOI: 10.3969/j.issn.1001-5256.2017.12.014.
Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. J Clin Hepatol, 2017, 33(12): 2326-2330. DOI: 10.3969/j.issn.1001-5256.2017.12.014.
Citation: Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. J Clin Hepatol, 2017, 33(12): 2326-2330. DOI: 10.3969/j.issn.1001-5256.2017.12.014.

半胱氨酰白三烯受体1在胰腺癌组织中的表达及临床意义

DOI: 10.3969/j.issn.1001-5256.2017.01.029
详细信息
  • 中图分类号: R735.9

Expression of cysteinyl leukotriene receptor-1 in pancreatic cancer tissue and its clinical significance

  • 摘要:

    目的探讨半胱氨酰白三烯受体(Cys LTR)1在胰腺癌组织中的表达及其与临床特征和预后的关系。方法选取2015年1月-10月葫芦岛中心医院收治的病理确诊为胰腺癌的患者42例,收集癌组织及癌旁组织,采用real-time PCR检测组织Cys LTR-1 mRNA相对表达量,并对患者随访1年。计量资料两组间比较采用t检验;多组间比较采用方差分析,进一步两两比较采用LSD-t检验。胰腺癌患者预后的影响因素采用多因素logistic回归分析。结果癌组织中Cys LTR-1 mRNA相对表达量高于癌旁组织,差异有统计学意义(0.037 1±0.020 5 vs 0.016 8±0.011 4,t=6.58,P<0.001);Cys LTR-1 mRNA相对表达量与患者的TNM分期(t=2.731,P=0.009)、分化程度(F=10.537,P<0.001)和淋巴结转移相关(t=3.408,P=0.002)。随访期内死亡17例,存活25例;死亡患者Cys LTR-1 mRNA相对表达量高于存活患者(0.045 6±0.021 7 vs 0.031 3±0.019 8),差异有统计学...

     

  • [1]GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specific all-cause and cause-specific mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2015,385(9963):117-171.
    [2]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
    [3]CONROY T,BACHET JB,AYAV A,et al.Current standards and new innovative approaches for treatment of pancreatic cancer[J].Eur J Cancer,2016,57:10-22.
    [4]ZAMBIRINIS CP,PUSHALKAR S,SAXENA D,et al.Pancreatic cancer,inflammation,and microbiome[J].Cancer J,2014,20(3):195-202.
    [5]PU J,LI X,ZHU J,et al.Expression and roles of poly(ADP-ribose)polymerase-1 and caspase-3 in pancreatic cancer and adjacent tissues[J].J Clin Hepatol,2016,32(2):337-341.(in Chinese)蒲竞,李汛,朱骏,等.PARP-1和caspase-3在胰腺癌及癌旁组织中的表达及意义[J].临床肝胆病杂志,2016,32(2):337-341.
    [6]SAVARI S,VINNAKOTA K,ZHANG Y,et al.Cysteinyl leukotrienes and their receptors:bridging inflammation and colorectal cancer[J].World J Gastroenterol,2014,20(4):968-977.
    [7]JIANG KR,HU H,MIAO Y.Value of artery resection in pancreatic cancer surgery[J].J Clin Hepatol,2016,32(5):826-829.(in Chinese)蒋奎荣,胡浩,苗毅.联合动脉切除在胰腺癌手术中的价值[J].临床肝胆病杂志,2016,32(5):826-829.
    [8]YANG YM.Highlights and diffculties in surgical treatment for pancreatic cacinoma[J].Chin J Dig surg,2015,14(8):612-614.(in Chinese)杨尹默.胰腺癌外科治疗的热点与难点[J].中华消化外科杂志,2015,14(8):612-614.
    [9]HENNIG R,DING XZ,TONG WG,et al.5-Lipoxygenase and leukotriene B(4)receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue[J].Am J Pathol,2002,161(2):421-428.
    [10]WANG X,LIU W,HAN YW,et al.Significance of cysteinyl leukotriene receptor in breast cancer[J].Chin J Clin Oncol,2012,39(20):1522-1526.(in Chinese)王欣,刘伟,韩芸蔚,等.半胱氨酰白三烯受体在乳腺癌组织中的表达及意义[J].中国肿瘤临床,2012,39(20):1522-1526.
    [11]ZHANG SQ,TANG CB,CHEN WH.Expression of Cys LT1R in colorectal carcinoma tissues and its clinical significance[J].J Shanxi Med Univ,2014,45(3):177-179.(in Chinese)张世强,唐采白,陈卫花.半胱氨酰白三烯受体Cys LT1R在大肠癌组织中的表达及临床意义[J].山西医科大学学报,2014,45(3):177-179.
    [12]MEZHYBOVSKA M,WIKSTROM K,OHD JF,et al.The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells[J].J Biol Chem,2006,281(10):6776-6784.
    [13]DING X,ZHU C,QIANG H,et al.Enhancing antitumor effects in pancreatic cancer cells by combined use of COX-2 and 5-LOX inhibitors[J].Biomed Pharmacother,2011,65(7):486-490.
  • 期刊类型引用(2)

    1. 中国抗癌协会肿瘤消融治疗专业委员会,中国临床肿瘤学会肿瘤消融治疗专家委员会,中国医师协会介入医师分会介入围手术学组. 复合式冷热消融治疗肝肿瘤围手术期管理专家共识. 中华内科杂志. 2025(02): 110-118 . 百度学术
    2. 温钊,臧铁柱,宋晓改,张炫,江艳丽. 射频消融治疗包膜下与非包膜下早期肝细胞癌患者的远期预后. 河南医学研究. 2023(15): 2738-2744 . 百度学术

    其他类型引用(0)

  • 加载中
计量
  • 文章访问数:  2553
  • HTML全文浏览量:  50
  • PDF下载量:  445
  • 被引次数: 2
出版历程
  • 出版日期:  2017-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回